These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11150389)

  • 1. The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats.
    Takusagawa M; Komori S; Matsumura K; Osada M; Kohno I; Umetani K; Ishihara T; Sawanobori T; Ijiri H; Tamura K
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):105-12. PubMed ID: 11150389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts.
    Tosaki A; Droy-Lefaix MT; Pali T; Das DK
    Free Radic Biol Med; 1993 Apr; 14(4):361-70. PubMed ID: 8385645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury.
    Brunvand H; Frłyland L; Hexeberg E; Rynning SE; Berge RK; Grong K
    Eur J Pharmacol; 1996 Oct; 314(1-2):99-107. PubMed ID: 8957224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury.
    Khaper N; Rigatto C; Seneviratne C; Li T; Singal PK
    J Mol Cell Cardiol; 1997 Dec; 29(12):3335-44. PubMed ID: 9441839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T; Ito S; Aoyama M; Takeda Y; Suzumura H; Nakata K; Yamada Y; Suzuki S; Fukutomi T; Itoh M
    Eur J Pharmacol; 2001 Jan; 412(2):145-53. PubMed ID: 11165226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    Christopher TA; Lopez BL; Yue TL; Feuerstein GZ; Ruffolo RR; Ma XL
    J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
    Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
    Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms.
    Brunvand H; Kvitting PM; Rynning SE; Berge RK; Grong K
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):409-17. PubMed ID: 8877588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats.
    Kumar A; Prakash A; Dogra S
    Pharmacol Rep; 2011; 63(4):915-23. PubMed ID: 22001979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol.
    Nagano T; O'Harrow S; Sponer G; Zimmer HG
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):530-6. PubMed ID: 7681896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
    Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
    de Mey C; Breithaupt K; Schloos J; Neugebauer G; Palm D; Belz GG
    Clin Pharmacol Ther; 1994 Mar; 55(3):329-37. PubMed ID: 7908256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?
    El-Sherif N; Turitto G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):985-90. PubMed ID: 16176541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol and antioxidant proteins in a type I diabetes animal model.
    Diogo CV; Deus CM; Lebiedzinska-Arciszewska M; Wojtala A; Wieckowski MR; Oliveira PJ
    Eur J Clin Invest; 2017 Jan; 47(1):19-29. PubMed ID: 27805735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
    Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.